Articles By Marcus Johnson

  1. Medivation And Astellas Pharma Prostate Cancer Drug Looks Promising 1/30/2014

    The prostate cancer drug Xtandi, when used before chemotherapy, delayed the growth of tumors and lengthened the lives of men who had advanced stage prostate cancer. Xtandi was also able to lower the risk of cancer worsening and lengthened the time period before chemotherapy was medically necessary.

  2. Did Pharmaceutical Companies Withhold Information In Clinical Trials? 1/28/2014

    Doctors say that without the full information from clinical trials, they struggle to make an informed decision on drug prescriptions. In the United Kingdom, concern has stemmed from the clinical trials of the drug Tamiflu, the results of which have not been fully published. Still, the country’s Department of Health continued to spend nearly 425 million pounds on the drug. Because of the lack of information from clinical trials, doctors don’t agree on how Tamiflu should be used or prescribed to patients.

  3. Health Startup Gets $15 Million In Funding 1/21/2014

    In an effort to become more efficient, the healthcare industry is starting to turn to analytics and big data companies who can help them sort through the millions of pieces of data that they have to keep track of on a daily basis.

  4. Cloud Technology Set To Affect The Life Science Industry 1/21/2014

    Due to a number of factors, life sciences companies are joining the world of high technology. That means that health and technology companies are moving many of their records and processes to cloud technology.